Evidence map›Paper›PMID 37077564›Full record

ArticleFrontiers in neurology2023

Solving inherited white matter disorder etiologies in the neurology clinic: Challenges and lessons learned using next-generation sequencing.

Stefanie Perrier, Kether Guerrero, Luan T Tran, Mackenzie A Michell-Robinson, Geneviève Legault, Bernard Brais, Michel Sylvain, James Dorman, Michelle Demos, Wolfgang Köhler and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 3 countries.

Stefanie PerrierDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Kether GuerreroDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Luan T TranDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Mackenzie A Michell-RobinsonDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Geneviève LegaultDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Bernard BraisDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Michel SylvainDivision of Pediatric Neurology, Centre Mère-Enfant Soleil du CHU de Québec - Université Laval, Québec City, QC, Canada.
James DormanJohn H. Stroger Jr. Hospital of Cook County, Chicago, IL, United States.
Michelle DemosDivision of Neurology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.
Wolfgang KöhlerLeukodystrophy Center, University of Leipzig Medical Center, Leipzig, Germany.
Tomi PastinenGenomic Medicine Center, Children's Mercy Hospital, Kansas City, MO, United States.
Isabelle ThiffaultGenomic Medicine Center, Children's Mercy Hospital, Kansas City, MO, United States.
Geneviève BernardDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
McGill University Health Centre · CAMcGill University · CABC Children's Hospital · CAChildren's Mercy Hospital · USLeipzig University · DEMontreal Neurological Institute and Hospital · CARush University Medical Center · USUniversité Laval · CAUniversity of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rare neurodevelopmental disorders, including inherited white matter disorders or leukodystrophies, often present a diagnostic challenge on a genetic level given the large number of causal genes associated with a range of disease subtypes. This study aims to demonstrate the challenges and lessons learned in the genetic investigations of leukodystrophies through presentation of a series of cases solved using exome or genome sequencing. Methods: Each of the six patients had a leukodystrophy associated with hypomyelination or delayed myelination on MRI, and inconclusive clinical diagnostic genetic testing results. We performed next generation sequencing (case-based exome or genome sequencing) to further investigate the genetic cause of disease. Results: Following different lines of investigation, molecular diagnoses were obtained for each case, with patients harboring pathogenic variants in a range of genes including Discussion: This study illustrates the importance of applying a collaborative diagnostic approach by combining detailed phenotyping data and metabolic results from the clinical environment with advanced next generation sequencing analysis techniques from the research environment to increase the diagnostic yield in patients with genetically unresolved leukodystrophies.

Indexed as

genetic diagnosishypomyelinationleukodystrophymedical geneticsneurogeneticsnext generation sequencing (NGS)pediatric neurologywhite matter disorders

Identifiers

PMID37077564
PMCPMC10108901
OpenAlexW4362589041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.